These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12197941)

  • 1. Determination of arterial blood ammonia in uremic patients before and after hemodialysis using three different ammonia methods.
    Huizenga JR; Mulder B; Stegeman CA; Ament W; Teelken AW
    Artif Organs; 2002 Sep; 26(9):815-6; author reply 816. PubMed ID: 12197941
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriovenous difference of blood ammonia in uremic patients under hemodialysis.
    Agroyannis B; Tzanatos H; Fourtounas C; Kopelias I; Katsoudas S; Chondros K
    Artif Organs; 1998 Aug; 22(8):703-5. PubMed ID: 9702323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of blood ammonia alterations in uremic patients under hemodialysis and CAPD.
    Agroyannis B; Tzanatos H; Chondros K; Fourtounas C; Kopelias I; Bougatsos G; Voudiclaris S; Koutsikos D
    Int J Artif Organs; 1994 May; 17(5):307-8. PubMed ID: 7960200
    [No Abstract]   [Full Text] [Related]  

  • 5. Is blood ammonia influenced by kidney function? A prospective study.
    Imran M; Shah Y; Nundlall S; Roberts NB; Howse M
    Clin Biochem; 2012 Mar; 45(4-5):363-5. PubMed ID: 22240068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of various organs to ammonia formation. Factors determining the arterial concentration.
    Agroyannis B; Tzanatos H; Koutsikos D
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():210-1. PubMed ID: 9133261
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperammonemic encephalopathy due to vitamin D-induced hypercalcemia in a uremic patient.
    Oymak O; Akpolat T; Arik N; Yasavul U; Turgan C; Cağlar S
    Nephron; 1994; 66(3):369. PubMed ID: 8190198
    [No Abstract]   [Full Text] [Related]  

  • 8. Liquid-chromatographic determination of inosine, xanthine, and hypoxanthine in uremic patients receiving hemodialysis treatment.
    Severini G; Aliberti LM
    Clin Chem; 1987 Dec; 33(12):2278-80. PubMed ID: 3690845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An abnormal lipoprotein in the serum of uremic patients maintained on chronic hemodialysis.
    Papadopoulos NM; Borer WZ; Elin RJ; Diamond LH
    Ann Intern Med; 1980 May; 92(5):634-5. PubMed ID: 7387005
    [No Abstract]   [Full Text] [Related]  

  • 11. The beginning of repeated hemodialysis treatment enhances some platelet functions in uremic patients.
    Krawczyk W; Dmoszýnska A; Marczewski K
    Nephron; 1995; 71(3):361-2. PubMed ID: 8569990
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
    Kario K; Matsuo T; Yamada T; Matsuo M
    Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis.
    Minamisono T; Wada M; Akamatsu A; Okabe M; Handa Y; Morita T; Asagami C; Naito HK; Nakamoto S; Lewis LA; Mise J
    Clin Chim Acta; 1978 Mar; 84(1-2):163-72. PubMed ID: 639300
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between plasma phosphate concentration and hematocrit in uremic patients undergoing hemodialysis.
    Gonella M
    Nephron; 1980; 26(2):100. PubMed ID: 7412960
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients.
    Perna AF; Di Nunzio A; Amoresano A; Pane F; Fontanarosa C; Pucci P; Vigorito C; Cirillo G; Zacchia M; Trepiccione F; Ingrosso D
    Biochimie; 2016 Jul; 126():97-107. PubMed ID: 27129884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control.
    Alarabi AA; Wikström B; Danielson BG
    Contrib Nephrol; 1991; 93():61-4. PubMed ID: 1802603
    [No Abstract]   [Full Text] [Related]  

  • 17. [Affinity of hemoglobin for oxygen in uremic patients treated with periodic hemodialysis. Comparison of the pre- and post-dialytic phases].
    Bernasconi C; Stabilini R; Graziani G; Agostoni A
    Minerva Med; 1973 Nov; 64(84):4458-62. PubMed ID: 4771470
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis.
    Frangos-Plemenos M; Agroyannis B; Koutsicos D; Tzanatos-Exarchou H; Logothetis E; Sarris E; Kaya S; Yatzidis H
    Int J Artif Organs; 1987 May; 10(3):195-8. PubMed ID: 3610372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.